alphaveSUPRIYA₹919.40

Supriya Lifescience Ltd.

₹ CrorePeersSTAR SPARC THYROCARE SHILPAMED VIYASH RUBICON YATHARTH PARKHOSPS

Comp Set

In ₹ Crore except Per Share Latest Annual	SUPRIYA FY25	STAR FY26	SPARC FY26	THYROCARE FY26	Peer Median
Valuation — at last close
P/E	—	20.07×	◆ 4.11×	54.33×	20.07×
P/B	—	◆ 3.54×	4.77×	15.15×	4.77×
EV/EBITDA	—	13.66×	◆ 4.34×	33.17×	13.66×
Market Cap	—	₹11,162 Cr	₹6,386 Cr	₹8,882 Cr	₹8,882 Cr
Growth
Revenue CAGR 3Y	—	9.62%	◆ 95.98%	16.33%	16.33%
Revenue CAGR 5Y	—	7.94%	—	◆ 10.88%	9.41%
Net Income CAGR 3Y	—	—	—	36.27%	36.27%
Revenue YoY (latest Q)	—	13.01%	◆ 314.11%	24.34%	24.34%
Net Income YoY (latest Q)	—	56.73%	◆ 59.94%	34.06%	56.73%
Profitability
EBITDA Margin	—	19.04%	◆ 85.08%	31.61%	31.61%
Net Income Margin	—	11.82%	◆ 82.65%	19.64%	19.64%
Return on Common Equity	—	17.66%	◆ 116.20%	27.82%	27.82%
Return on Capital Employed	—	17.93%	◆ 112.12%	31.92%	31.92%
Return on Assets	—	8.29%	◆ 71.55%	21.79%	21.79%
Credit & Quality
Total Debt/Equity	◆ 0.00×	0.53×	0.42×	0.00×	0.42× -100%
Interest Coverage	—	4.05×	46.54×	◆ 72.66×	46.54×
Scale — latest FY
Revenue / Total Income	—	₹4,859 Cr	₹1,879 Cr	₹829 Cr	₹1,879 Cr
Net Income	—	₹575 Cr	₹1,553 Cr	₹163 Cr	₹575 Cr
Total Assets	₹1,112 Cr	₹6,927 Cr	₹2,171 Cr	₹747 Cr	₹2,171 Cr -49%
EPS	—	₹60.34	₹47.86	₹10.27	₹47.86
Book Value per Share	—	₹341.68	₹41.26	₹36.82	₹41.26

◆ best value in the comp set per metric · Δ = subject vs median of the other companies.

« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 89%.